Wed, 02 Oct 2024 | BUSINESS SALE
Cheshire-headquartered healthcare business Helios Global Group is set to be acquired by Telemos Capital from private equity firm NorthEdge. Helios works with clients in the pharmaceutical and biotech industries, providing services including strategic consultancy, medical and scientific communications and commercialisation, as well as health economics and outcomes research (HEOR) and market access services.
The company secured investment from NorthEdge in 2021 and, since then, has tripled its revenues and more than tripled its staff headcount from 80 to nearly 300, whilst expanding its operations across the UK and US.
NorthEdge has supported Helios is establishing a material presence in the US and increased the company’s addressable market. Earlier this year, the company also completed the acquisition of HEOR and market access consultancy Cogentia, further expanding its specialist services and global scale.
NorthEdge partner Phil Frame said that the firm’s backing over the past three years has enabled Helios to “grow its national and international footprint, team and the number of clients it services”, calling the company “another great example of a successful, regionally headquartered business that has global reach and a genuine impact on health outcomes.”
Frame continued: “The exit of Helios represents our fourth regional healthcare deal in the last twelve months, following our investments into Latus Group, RoukenBio and Torbay Pharma, and demonstrates our commitment to supporting businesses in this sector to realise their strategic and social potential."
Helios Global Group Chief Executive Andrew Minnock added: "Our journey with private equity investment to date has been an incredibly positive and enabling experience. We would like to thank the NorthEdge team for their contribution to the growth and continued success of Helios over the past 3 and a half years."
The new investment from Telemos will support the company in delivering its growth plan, including expanding into new service lines and harnessing new innovative technologies, as well as continuing to scale its internal infrastructure in order to better support its client base.
Jacob Polny, CEO of Telemos, and Sami Kassam, Head of Healthcare, stated, “Our investment in Helios confirms our approach of investing in high-performing, well-managed businesses with potential for sustainable growth through international expansion, strategically aligned add-on acquisitions and operational improvements. We have been following Helios’ journey for a number of years and are delighted to be working with Andrew and the team to support the continued success of the group.”
Completion of the deal, subject to customary approvals, is expected in October 2024.
Find out more about how UK private equity investment could develop over the coming months, including the part that the healthcare sector might play
Opportunity to acquire a profitable Domiciliary Care agency, which is backed by a national Franchisor. With a strong management structure in place and a dedicated team of 17 carers, the business provides their area with the very best levels of suppor...
LEASEHOLD
A health clinic specialising in skincare and dermatology that can boast a diverse client base and consistent growth since the company was founded in 2011.
Owner operated for over 20 years, this business has built up a strong reputation in the London borough it operates in. The company has a contract worth up to £12 million, which has been extended to 2025.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.